Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol.

1. The short term effects of hydrallazine, oxprenolol and oxprenolol plus hydrallazine were studied in five patients with essential hypertension. 2. The increase in pulse rate caused by hydrallazine was prevented by combined treatment with oxprenolol, which also lowered the high plasma noradrenaline levels, associated with the use of hydrallazine. 3. Plasma renin activity was higher in the supine and standing positions with hydrallazine than with oxprenolol alone and with the patients standing this high renin level was prevented by simultaneous treatment with oxprenolol. With the patients supine, combination of oxprenolol with hydrallazine resulted in a mean plasma renin activity which was less than half that with hydrallazine alone, although this difference was not statistically significant. 4. The combination of oxprenolol with hydrallazine did not lower the blood pressure further, but reduced the increased sympathetic activity which occurred with hydrallazine alone.

[1]  P. Sever,et al.  Are racial differences in essential hypertension due to different pathogenetic mechanisms? , 1978, Clinical science and molecular medicine. Supplement.

[2]  P. Sever,et al.  PLASMA-NORADRENALINE IN ESSENTIAL HYPERTENSION , 1977, The Lancet.

[3]  A. Raine,et al.  Long term β-adrenergic blockade reduces tyrosine hydroxylase and dopamine β-hydroxylase activities in sympathetic ganglia , 1977, Nature.

[4]  J. Slater,et al.  IS THE ADRENERGIC CONTROL OF RENIN RELEASE DOMINANT IN MAN? , 1976, The Lancet.

[5]  D. Shand,et al.  Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. , 1976, The New England journal of medicine.

[6]  H. Kornerup,et al.  Effect of alprenolol and hydralazine on plasma renin concentration in patients with arterial hypertension. , 2009, Acta medica Scandinavica.

[7]  D. Johnson,et al.  A sensitive radioenzymatic assay for norepinephrine in tissues and plasma. , 1975, Life sciences.

[8]  A. Vedin,et al.  Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment. , 1972, The American journal of cardiology.

[9]  J. Koch-weser,et al.  Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade. , 1972, The New England journal of medicine.

[10]  Y. Kaneko,et al.  Observations on the Mechanism of Renin Release by Hydralazine in Hypertensive Patients , 1970, Circulation research.

[11]  G. W. Boyd,et al.  Radioimmunoassay determination of plasma-renin activity. , 1969, Lancet.

[12]  G. Rowe,et al.  Hemodynamic effects of 1-hydrazinophthalazine in patients with arterial hypertension. , 1955, The Journal of clinical investigation.

[13]  E. Freis,et al.  The Hemodynamic Effects of Hypotensive Drugs in Man: IV. 1‐Hydrazinophthalazine , 1953, Circulation.